anti-tau single-domain heavy chain antibody fragments (New York University school of medicine)

N/A

Report date: 2025/01/26 19:32:38

Base Information

Drug Nameanti-tau single-domain heavy chain antibody fragments (New York University school of medicine)
Drug Alias Nameanti-tau single chain variable antibody fragment (New York University school of medicine)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNew York University School Of Medicine
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A